The ␤-amyloid precursor protein (APP) plays a pivotal role in the early stages of neurodegeneration associated with Alzheimer's disease. An alteration in the processing pattern of the protein results in an increase in the generation of the 40-42-amino-acid ␤-amyloid (A␤) peptide, which coalesces to form insoluble, extracellular amyloid deposits. A greater understanding of the factors that influence APP processing may assist in the design of effective therapeutic agents to halt progression of Alzheimer's disease. APP is a sialoglycoprotein with two potential N-linked glycosylation sites, one of which may contain a complex oligosaccharide chain. An alteration in the glycosylation state of APP by the generation of oligomannosyl oligosaccharides results in a decrease in the secretion of the neuroprotective, soluble form of the protein and a parallel increase in the deposition of the cellular protein within the perinuclear region of the cell. Conversely, the attachment of additional terminal sialic acid residues on to the oligosaccharide chain results in an increase in secretion of soluble APP (sAPP␣). One factor that has been widely reported to alter APP processing is the activation of protein kinase C (PKC). This process has been characterized using synaptosomal preparations, which suggests that the PKC action is occurring at the level of the plasma membrane. Furthermore, when cells are transfected with the sialyltransferase enzyme, there is a direct relationship between the sialylation potential of APP and the fold stimulation of sAPP␣, after PKC activation. These results suggest that the post-translational modification of APP by glycosylation is a key event in determining the processing of the protein.
sion. All N-linked carbohydrates share a common pentasaccharide core structure called the trimannosyl core, which consists of two GlcNAc residues (one of which is attached to Asn of the polypeptide chain) and three mannose (Man) residues in the format Man␣1,3-(Man␣1,6)-Man␣1,4-GlcNAc␤1,4-GlcNAcAsn. N-linked sugar chains can be subdivided subsequently into three main categories according to the variation and linkage point of the peripheral sugar residues: high-mannose, complex and hybrid N-linked oligosaccharides ( Figure 1) .
The high-mannose-type glycans contain only ␣-mannosyl residues outside the pentasaccharide core (Figure 1a ), whereas complex oligosaccharides contain either lactosamine units (Gal␣1,4-GlcNAc or Gal␣1,3-GlcNAc) or sialolactosamine units (NeuNAc linked via an ␣2,3 to lactosamine) attached to the mannose residues of the trimannosyl core (Figure 1b) . Complex-type oligosaccharides can be highly branched, depending on the substitution pattern of the GlcNAc residues to the mannose residues in the core. The complex sugar chains may also be sulphated, fucosylated or phosphorylated, and usually con- tain a negatively charged terminal sialic acid (NeuNAc) residue. The hybridtype glycans combine certain structural features of both the high-mannose and the complex types. For example, one arm of the trimannosyl core may be of high-mannose-type glycan, whereas the other arm may be of a complex-type glycan (Figure 1c ). Because of their negative charge, the terminal NeuNAc residues play a particular role in influencing the structure and function of the protein backbone. The role of NeuNAc residues is illustrated well in the structure and function of the neural cell adhesion molecule (NCAM). NCAM plays a pivotal role in the mediation of cell-cell interaction. During embryogenesis, and again coincident with plastic events in the mature central nervous system (CNS), NCAM contains polysialic acid (PSA) chains in which up to 50 NeuNAc residues are attached by ␣2,8 linkages in an N-linked oligosaccharide chain. PSA acts to prevent the homophilic binding of the NCAM backbone and this serves to prevent the premature formation of synapses during development. It also allows for synaptic rearrangement in the adult. PSA has been shown to play a role in memory formation [10] , as well as in long-term potentiation (LTP), which is an electrophysiological paradigm of synaptic plasticity [11] . In fact, recent studies have proposed that PSA plays a role in the maintenance of LTP (which is associated with synaptic rearrangement) rather than in its induction (which is receptor mediated) [12] .
Glycosylation of ␤-amyloid precursor protein (APP)
APP is a transcribed sialoglycoprotein that exists as three primary isoforms: APP 695 , APP 751 and APP 770 (the numbers referring to the number of amino acids in the protein). Both APP 751 and APP 770 contain the 56-aminoacid Kunitz protease inhibitor (KPI) domain and, in addition, APP 770 contains a 19-amino-acid insert that codes for an Ox-2 (the MRC Ox-2 antigen) domain [13] [14] [15] .
There are two mutually exclusive pathways which serve to process APP: cleavage at Lys 16 , within the ␤-amyloid (A␤) region of the protein, by the ␣-secretase results in the generation of soluble APP (sAPP␣); alternatively, it can be cleaved by the ␤-and ␥-secretases to generate the 40-42-amino-acid A␤ peptide [16, 17] . Furthermore, the processing mechanisms may be cell, tissue or species specific.
APP trafficking in non-polarized cells indicates that the protein is delivered to the cell surface via a constitutive biosynthetic pathway, where it can be cleaved by ␣-secretase and secreted as sAPP␣. Alternatively, it can be internalized by endocytosis and eventually degraded by an endosomal/lysosomal pathway, with the generation of the A␤ peptide [18] [19] [20] . However, there is an increasing body of evidence to suggest that A␤ may also be generated at the level of the ER and Golgi [21] [22] [23] .
The APP holoprotein is multifunctional, with the membrane-bound form playing a role in cell-cell adhesion and in cellular interaction with the extracellular matrix [24, 25] . The soluble (secreted) form of the protein exhibits both neuroprotective and neurotropic effects [26] . These functions of the pro-tein may be responsible, at least in part, for its role in memory/learning [27, 28] and in the induction of LTP [29, 30] . Transgenic mice overexpressing the mutated human APP 695 (APP 695 SWE), which exhibit some of the pathological hallmarks of AD, also demonstrate an impairment in synaptic plasticity [31] .
APP contains two potential N-linked oligosaccharide attachment sites (Asn 467 and Asn 496 ), although the available evidence suggests that only the former may be occupied under normal conditions [32] . APP may also contain Olinked oligosaccharide chains [33, 34] . Previous studies have proposed that the N-linked oligosaccharide chain on sAPP␣ is of the complex type, with a fucosylated core [35] and a terminal NeuNAc residue [36] . These results have been confirmed by lectin blot analysis of sAPP␣ labelled with the Lens culinaris (LcH), Phaseolus vulgaris (PHA-L) and Maackia amurensis (MAA) lectins ( Figure 2) . Each of the lectins recognizes a specific sugar residue or short oligosaccharide sequence, and the use of multiple lectins allows for the generation of a composite profile of the oligosaccharide structure. The cellular holoprotein, however, exhibits a different oligosaccharide profile and, in particular, is labelled by the Datura stramonium lectin, which detects high-mannose-type oligosaccharides. This labelling, however, may reflect the diverse sugar profiles of the protein as it undergoes different stages of glycosylation on its pathway through the cell. The fact that the cellular form of APP contains a high-mannose-type (immature) oligosaccharide side-chain suggests that the majority of the particulate form of the protein is likely to be retained within the perinuclear region of the cell. In order for APP to be released from the ER/Golgi, for transportation to the plasma membrane and ultimately secretion, the predominant oligosaccharide side-chain is of the complex type. Since the protein has a very high turnover rate at the level of the plasma membrane, it is likely that only very low levels of the protein are actually expressed at the level of the cell surface at any one time. This is in good agreement with previous studies that have reported a relatively short half-life for the protein within the cell [37] [38] [39] . The rapid turnover of the protein at the level of the plasma membrane may explain the differences between the glycosylation patterns of the particulate APP (which is largely retained within the ER/Golgi and is of the high-mannose type) and the secreted form of the protein.
APP processing
It has been proposed that the oligosaccharide side-chains of APP play a pivotal role in the processing of the protein and a number of different model systems have been employed to determine the effect of altered glycosylation on APP processing. The Lec8 strain of mutant CHO cell lines have a defect in the CMP-NeuNAc transport system resulting in the expression of asialo-oligosaccharides [40] . Soluble inhibitors of the early stages of glycosylation, including tunicamycin and brefeldin A, have also been used to study the role of glycosylation in APP processing. APP secretion was diminished when core N-glycosylation or N-glycan processing (and particularly sialylation) was blocked [41] . It was proposed, however, that in addition to APP glycosylation itself, the glycosylation of other proteins may also be involved in APP processing. Alterations in protein glycosylation, either by tunicamycin or through the inhibition of mannosidase, also upset the axonal sorting of the protein both in vitro and in vivo [42] . A similar result was observed when the asparagine residues, to which the complex sugars are attached, were deleted [43] . Studies in this lab have used the mannosidase I and II inhibitors 2-deoxymannojirimycin (dMan) and swainsonine to investigate the differential effects of high mannose and complex sugars on APP processing [44] . Treatment of AtT-20 mouse pituitary cells in vitro with dMan or swainsonine, which prevents maturation of N-linked sugars, resulted in a significant decrease in the translocation of APP from the perinuclear region of the cell to the cell membrane and therefore in ultimate secretion (Figure 3 ). In addition, parallel in vivo studies were carried out using the hamster retinotectal projection as a model system. The dMan was injected intraocularly and the axonal transport of APP along the retinal ganglion cells was determined following dissection of the superior colliculus [45] . The prevention of oligosaccharide maturation by the inhibition of mannosidase action, significantly decreased the axonal transport of APP [46] . Taken together, these results confirm the earlier lectin studies that suggest the preferential transfer of APP, containing mature complex N-linked oligosaccharide chains, from the perinuclear region of the cell to the plasma membrane, with the high-mannose-containing forms of the protein being retained in the ER/Golgi complex. Although the presence of complex oligosaccharides may not be an absolute requirement for protein transport to the cell surface [47] , it certainly plays a significant role in APP processing and trafficking within the cell.
The retention of APP in the perinuclear region of the cell may also have implications for the final processing of the protein and in particular on the generation of the A␤ peptide. There is increasing evidence to suggest that A␤ may be generated, at least in part, at the level of the Golgi or ER [21] [22] [23] . Thus any factors, such as the impairment of oligosaccharide maturation, which retain the protein in the perinuclear region, preventing translocation to the plasma mem-brane, may lead to an increase in cellular A␤ concentration due to the build up of the holoprotein in the intermediate cellular compartment [16, 48] .
The pivotal role of the terminal sialic acid residue in APP processing has been confirmed using cells that overexpress the ␣2,6(N) sialyltransferase (ST6N) enzyme. Stably-transfected B104 rat neuroblastoma cells that overexpress the ST6N enzyme have been generated. These cells have specific enzyme activities reaching up to 20 times that of control (mock-transfected) cells and show a parallel increase in protein-bound ␣2,6 linked sialic acid [49, 50] . There was a marked decrease in the levels of particulate (cellular) APP in the transfected cells, which was accompanied by an increase in the secreted form of the protein (Figure 4) . [49] . APP was detected using the 790 antibody (directed against the A␤ region of the protein) and quantified by densitometric analysis [61] .
there was a tendency towards a decrease in the intensity of the lower band. Previous studies have proposed that the existence of multiple APP immunoreactive bands may reflect the expression of different glycoforms of the protein [36, 41] . Therefore, it is likely that the upper band is more highly glycosylated and the increase in its intensity reflects an increase in the sialic acid content of the protein.
Second messenger systems
The processing of APP can also be modulated by the action of extracellular stimuli such as metabotropic glutamate [51, 52] and cholinergic [53, 54] agonists, and also by various growth factors including epidermal growth factor [55] and nerve growth factor [56] . The activation of these receptors induces a potentiation of sAPP␣ secretion. The detailed mechanisms of the signalling pathways that are coupled to receptor-mediated sAPP␣ secretion remain to be clearly defined, although evidence implicates the hydrolysis of inositol phospholipid by phospholipase C in response to G-protein-coupled receptor activation [51] . The mitogen-activated protein kinase kinase (MEK) inhibitor PD 98059 [17, 56] blocks growth-factor-stimulation of sAPP␣ secretion, thus providing strong evidence that the action of growth factors operates via a tyrosine-kinase cascade. However, stimulation of sAPP␣ secretion by phorbol esters, which directly activate protein kinase C (PKC) by mimicking its physiological activator diacylglycerol, can also be blocked by the actions of PD 98059 [17, 56] .
From these studies, it is likely that PKC (or specific isoforms thereof) may serve as a convergent point for the pathways that stimulate sAPP␣ secretion. The mechanisms by which PKC activation potentiate sAPP␣ secretion, however, remain unknown. Although the C-terminus of sAPP␣ can be phosphorylated [57] [58] [59] , the degree of phosphorylation does not correlate with the PKC-mediated enhanced secretion [60, 61] and, in fact, deletion of the C-terminus of APP increased the basal rate of secretion [62] . This observation is of particular interest since one group has proposed that the basal secretion of sAPP␣ is independent of the PKC-induced stimulatory pathway [63] ; this theory is based on evidence generated using inhibitors of a proteasome complex which may contain the ␣-secretase. Recently, Racchi and colleagues [64] reported that both the constitutive and stimulatory pathways converge on a proteolytic complex which may represent the ␣-secretase. Perhaps, therefore, there is a crossregulation between the two pools of APP that feed into PKC-dependent and independent pathways.
Since the activation of PKC has also been shown to cause an accompanying reduction in the production of A␤ peptide [65, 66] , identifying the loci of its action could have significant therapeutic benefits. It has been shown that phorbol esters can act by stimulating vesicle budding from the Golgi apparatus [67] but, since phorbol esters can also enhance sAPP␣ secretion from isolated nerve terminals (synaptosomes) ( Figure 5 ) [61] , this would suggest that an additional PKC target may be at, or in close proximity to, the plasma membrane. However, in vivo, it is possible that events occurring at the level of the Golgi apparatus, such as glycosylation, can influence the subsequent transportation of APP to the nerve terminal [68] .
Recently it has been reported that PKC activation can influence cellular ST activity [69] [70] [71] . Therefore, as transfection of cells with ST6N results in increased trafficking of APP to the cell membrane (with a parallel up-regulation of sAPP␣ secretion) (Figure 4) , and PKC activation modulates the protein secretion at the level of the cell membrane, the transfected cells were used to investigate whether there may be an additive effect of the two controlling factors. In the control cells, treatment with carbachol (to activate muscarinic receptors) or phorbol esters resulted in increased APP secretion (Figure 6a ). The carbachol stimulation of sAPP␣ secretion from cells with high ST6N activity was similar to that observed in control cells. The phorbol-stimulated protein secretion, however, was markedly increased over the control cells ( Figure  6b ). This suggests that glycosylation (and specifically sialylation) not only stimulates the intracellular transport of APP, but also influences its subsequent processing at the level of the cell membrane. 
Conclusion
Because of the neuroprotective role of soluble APP and the role of the membrane-bound form in cell adhesion, both of which may modulate the role of the protein in synaptic plasticity, any changes in the glycosylation state of the cell that result in an increase in the intracellular protein levels, and a parallel decrease in the rate of secretion, may have a significant effect on neuronal function. Indeed, there is some evidence for an association between altered protein glycosylation and Alzheimer's disease pathology, although it is not clear whether this is an early or late event in the disease [72, 73] . Further studies will need to be carried out in order to gain a clearer understanding of the role of glycosylation in APP processing and A␤ generation and to determine whether altered protein glycosylation may be a key early event in the onset of Alzheimer's disease.
